Liver Disease Clinical Trial 20203235

[LCID Study Number: 20203235]

Pilot study to evaluate the prevalence of NAFLD in genetically high-risk living-liver donors and recipients using MRI-PDFF and evaluate the diagnostic accuracy novel ultrasound techniques for fat quantification against MRI-PDFF

The purpose of this study is to evaluate the prevalence of NAFLD in genetically high-risk living-liver donors and recipients using MRI-PDFF and evaluate the diagnostic accuracy novel ultrasound techniques for fat quantification against MRI-PDFF.

Disease/Condition: Liver Disease

Department: Radiology

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: nanette.matrullo@lahey.org

Primary Contact Phone: 781-744-2906